QQQ   423.39 (-0.58%)
AAPL   166.67 (-0.79%)
MSFT   406.63 (-1.27%)
META   504.11 (+2.01%)
GOOGL   156.53 (+0.68%)
AMZN   179.10 (-1.20%)
TSLA   149.80 (-3.63%)
NVDA   845.59 (+0.62%)
AMD   154.23 (+0.14%)
NIO   4.03 (+3.07%)
BABA   68.96 (+0.20%)
T   16.21 (+0.56%)
F   12.02 (-0.17%)
MU   112.99 (-2.87%)
GE   154.25 (-0.91%)
CGC   8.06 (+24.19%)
DIS   112.91 (-0.03%)
AMC   2.87 (-3.69%)
PFE   25.29 (-0.51%)
PYPL   62.22 (-1.64%)
XOM   118.40 (-0.19%)
QQQ   423.39 (-0.58%)
AAPL   166.67 (-0.79%)
MSFT   406.63 (-1.27%)
META   504.11 (+2.01%)
GOOGL   156.53 (+0.68%)
AMZN   179.10 (-1.20%)
TSLA   149.80 (-3.63%)
NVDA   845.59 (+0.62%)
AMD   154.23 (+0.14%)
NIO   4.03 (+3.07%)
BABA   68.96 (+0.20%)
T   16.21 (+0.56%)
F   12.02 (-0.17%)
MU   112.99 (-2.87%)
GE   154.25 (-0.91%)
CGC   8.06 (+24.19%)
DIS   112.91 (-0.03%)
AMC   2.87 (-3.69%)
PFE   25.29 (-0.51%)
PYPL   62.22 (-1.64%)
XOM   118.40 (-0.19%)
QQQ   423.39 (-0.58%)
AAPL   166.67 (-0.79%)
MSFT   406.63 (-1.27%)
META   504.11 (+2.01%)
GOOGL   156.53 (+0.68%)
AMZN   179.10 (-1.20%)
TSLA   149.80 (-3.63%)
NVDA   845.59 (+0.62%)
AMD   154.23 (+0.14%)
NIO   4.03 (+3.07%)
BABA   68.96 (+0.20%)
T   16.21 (+0.56%)
F   12.02 (-0.17%)
MU   112.99 (-2.87%)
GE   154.25 (-0.91%)
CGC   8.06 (+24.19%)
DIS   112.91 (-0.03%)
AMC   2.87 (-3.69%)
PFE   25.29 (-0.51%)
PYPL   62.22 (-1.64%)
XOM   118.40 (-0.19%)
QQQ   423.39 (-0.58%)
AAPL   166.67 (-0.79%)
MSFT   406.63 (-1.27%)
META   504.11 (+2.01%)
GOOGL   156.53 (+0.68%)
AMZN   179.10 (-1.20%)
TSLA   149.80 (-3.63%)
NVDA   845.59 (+0.62%)
AMD   154.23 (+0.14%)
NIO   4.03 (+3.07%)
BABA   68.96 (+0.20%)
T   16.21 (+0.56%)
F   12.02 (-0.17%)
MU   112.99 (-2.87%)
GE   154.25 (-0.91%)
CGC   8.06 (+24.19%)
DIS   112.91 (-0.03%)
AMC   2.87 (-3.69%)
PFE   25.29 (-0.51%)
PYPL   62.22 (-1.64%)
XOM   118.40 (-0.19%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
$0.00
$0.02
$0.00
$0.09
$43K-0.14103 shsN/A
Avitar, Inc. stock logo
AVTI
Avitar
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Bionik Laboratories Corp. stock logo
BNKL
Bionik Laboratories
$0.16
$0.03
$2.90
$1.25M-1.22N/AN/A
PCGR
PC Group
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Pathfinder Cell Therapy, Inc. stock logo
PFND
Pathfinder Cell Therapy
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
0.00%0.00%-98.50%-98.48%-98.77%
Avitar, Inc. stock logo
AVTI
Avitar
0.00%0.00%0.00%0.00%0.00%
Bionik Laboratories Corp. stock logo
BNKL
Bionik Laboratories
0.00%0.00%0.00%0.00%-71.43%
PCGR
PC Group
0.00%0.00%0.00%0.00%0.00%
Pathfinder Cell Therapy, Inc. stock logo
PFND
Pathfinder Cell Therapy
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Avitar, Inc. stock logo
AVTI
Avitar
N/AN/AN/AN/AN/AN/AN/AN/A
Bionik Laboratories Corp. stock logo
BNKL
Bionik Laboratories
N/AN/AN/AN/AN/AN/AN/AN/A
PCGR
PC Group
N/AN/AN/AN/AN/AN/AN/AN/A
Pathfinder Cell Therapy, Inc. stock logo
PFND
Pathfinder Cell Therapy
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
N/AN/AN/AN/A
Avitar, Inc. stock logo
AVTI
Avitar
N/AN/AN/AN/A
Bionik Laboratories Corp. stock logo
BNKL
Bionik Laboratories
N/AN/AN/AN/A
PCGR
PC Group
N/AN/AN/AN/A
Pathfinder Cell Therapy, Inc. stock logo
PFND
Pathfinder Cell Therapy
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
$270K0.16N/AN/A($0.11) per share-0.01
Avitar, Inc. stock logo
AVTI
Avitar
N/AN/AN/AN/AN/AN/A
Bionik Laboratories Corp. stock logo
BNKL
Bionik Laboratories
$1.80M0.00N/AN/A($0.24) per share0.00
PCGR
PC Group
N/AN/AN/AN/AN/AN/A
Pathfinder Cell Therapy, Inc. stock logo
PFND
Pathfinder Cell Therapy
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
-$510KN/A0.00N/AN/AN/AN/AN/A
Avitar, Inc. stock logo
AVTI
Avitar
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Bionik Laboratories Corp. stock logo
BNKL
Bionik Laboratories
-$4.95M-$0.710.00N/AN/AN/AN/AN/AN/A
PCGR
PC Group
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Pathfinder Cell Therapy, Inc. stock logo
PFND
Pathfinder Cell Therapy
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
N/AN/AN/AN/AN/A
Avitar, Inc. stock logo
AVTI
Avitar
N/AN/AN/AN/AN/A
Bionik Laboratories Corp. stock logo
BNKL
Bionik Laboratories
N/AN/AN/AN/AN/A
PCGR
PC Group
N/AN/AN/AN/AN/A
Pathfinder Cell Therapy, Inc. stock logo
PFND
Pathfinder Cell Therapy
N/AN/AN/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
1770.90 million46.72 millionNot Optionable
Avitar, Inc. stock logo
AVTI
Avitar
36N/AN/ANot Optionable
Bionik Laboratories Corp. stock logo
BNKL
Bionik Laboratories
1212.48 million8.15 millionNot Optionable
PCGR
PC Group
289N/AN/ANot Optionable
Pathfinder Cell Therapy, Inc. stock logo
PFND
Pathfinder Cell Therapy
1N/AN/ANot Optionable

BNKL, ABMT, AVTI, PFND, and PCGR Headlines

SourceHeadline
t-cell therapyt-cell therapy
hackaday.com - October 31 at 9:01 AM
Grail Pathfinder Publication Offers Glimpse of Multi-Cancer Clinical Screening ImpactsGrail Pathfinder Publication Offers Glimpse of Multi-Cancer Clinical Screening Impacts
precisionmedicineonline.com - October 13 at 7:43 AM
Pathfinder Cell Therapy, Inc. (PFND)Pathfinder Cell Therapy, Inc. (PFND)
finance.yahoo.com - October 10 at 11:08 PM
Whats the Treatment for Nonmelanoma Skin Cancer?What's the Treatment for Nonmelanoma Skin Cancer?
webmd.com - October 7 at 10:32 AM
Dendritic Cell Therapy for Type 1 Diabetes SuppressionDendritic Cell Therapy for Type 1 Diabetes Suppression
medscape.com - October 6 at 11:06 PM
Final Results From PATHFINDER Study of GRAILs Multi-Cancer Early Detection Blood Test Published in The LancetFinal Results From PATHFINDER Study of GRAIL's Multi-Cancer Early Detection Blood Test Published in The Lancet
benzinga.com - October 5 at 8:31 PM
Cell Therapy Repairs Cornea Damage With Patient’s Own Stem CellsCell Therapy Repairs Cornea Damage With Patient’s Own Stem Cells
technologynetworks.com - September 10 at 8:27 PM
Stem cell therapy for type 1 diabetes mellitusStem cell therapy for type 1 diabetes mellitus
nature.com - August 22 at 5:15 PM
Cell Replacement Therapy for Parkinsons DiseaseCell Replacement Therapy for Parkinson's Disease
medscape.com - August 20 at 7:49 AM
Gene and Cell TherapyGene and Cell Therapy
technologynetworks.com - August 17 at 5:48 PM
Third- and Further-line Therapy in Advanced Non-small-cell Lung Cancer PatientsThird- and Further-line Therapy in Advanced Non-small-cell Lung Cancer Patients
medscape.com - August 2 at 2:09 AM
Tail spin: Study reveals new way to reduce friendly fire in cell therapyTail spin: Study reveals new way to reduce friendly fire in cell therapy
medicalxpress.com - August 1 at 11:08 AM
UB, partner awarded $3 million NIH grant to study immune cell therapy for tumorsUB, partner awarded $3 million NIH grant to study immune cell therapy for tumors
buffalo.edu - July 19 at 3:42 PM
Stem Cell Therapy News, Research and Latest UpdatesStem Cell Therapy News, Research and Latest Updates
medindia.net - July 10 at 1:40 PM
Your First Therapy SessionYour First Therapy Session
psychologytoday.com - June 28 at 7:44 AM
Therapy for Teens: What to ExpectTherapy for Teens: What to Expect
webmd.com - June 25 at 6:51 PM
Topical Imiquimod Therapy for Cutaneous T-Cell LymphomaTopical Imiquimod Therapy for Cutaneous T-Cell Lymphoma
medscape.com - June 13 at 11:43 AM
Therapy: Does It Ever End?Therapy: Does It Ever End?
webmd.com - June 12 at 7:23 PM
New multiple myeloma cell therapy yields dramatic resultsNew multiple myeloma cell therapy yields dramatic results
israel21c.org - June 11 at 11:23 PM
B-Cell Therapy for Multiple Sclerosis: Be InformedB-Cell Therapy for Multiple Sclerosis: Be Informed
webmd.com - June 9 at 7:11 PM
Cellular Origins partners with ScaleReady to simplify, standardise, and automate cell therapy manufacturingCellular Origins partners with ScaleReady to simplify, standardise, and automate cell therapy manufacturing
news-medical.net - June 7 at 1:09 PM
New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection TestingNew PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing
businesswire.com - June 3 at 7:12 PM
Bluebird Sickle Cell Gene Therapy Falls Short of High ExpectationsBluebird Sickle Cell Gene Therapy Falls Short of High Expectations
thestreet.com - May 11 at 11:54 PM
How advanced flow cytometry could transform cell and gene therapyHow advanced flow cytometry could transform cell and gene therapy
news-medical.net - May 11 at 8:51 AM

Media Sentiment Over Time

Company Descriptions

Advanced BioMedical Technologies logo

Advanced BioMedical Technologies

OTCMKTS:ABMT
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.
Avitar logo

Avitar

OTCMKTS:AVTI
Avitar, Inc. is a holding company which through its subsidiaries designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine such as crack; marijuana; and methamphetamines, including meth and ecstasy. The company also provides foam disposable products including medical-grade hydrophilic polyurethane foam disposables such as wound dressings comprising Hydrasorb, a wound dressing product for exudating wounds; and various custom foam products comprising a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. In addition, it develops specialty wound dressings for the cardiac catheter lab market, as well as the Illizarov Dressing used for dressing external bone fixators in orthopedic procedures. The company markets its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies, schools, and corporations through direct sales force and strategic partners, as well as through a network of distributors. Avitar, Inc. was founded in 1986 and is based in Canton, Massachusetts with Additional office in Calgary, Canada.
Bionik Laboratories logo

Bionik Laboratories

OTCMKTS:BNKL
Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.

PC Group

OTCMKTS:PCGR
PC Group, Inc., through its subsidiaries, offers personal care products for the private label retail, medical, and therapeutic markets primarily in the United States, Canada, and Europe. Its personal care products include soaps, cleansers, toners, moisturizers, exfoliants, and facial masks, as well as over-the-counter drug products, such as acne soaps; and gel-based products, including gloves and sock products that are used for cosmetic and scar management purposes. The company's gel-based orthopedic products include digitcare products, diabetes management products, products that protect the hands and wrists, gel sheeting products for various applications, and pressure, friction, and shear force absorption products, as well as products for the treatment of common orthopedic and footcare conditions; and gel-based prosthetic products for the treatment of common orthopedic and footcare conditions. PC Group sells its personal care products through account representatives to health and beauty companies, specialty retailers, cosmetics companies, direct marketing companies, amenities companies, health clubs and spas, and catalog companies; and medical products through national and regional account managers, field sales representatives, and inside sales representatives, as well as through medical distributors. The company was formerly known as Langer, Inc. and changed its name to PC Group, Inc. in July 2009 as a result of business focus shift to personal care products business. PC Group, Inc. was founded in 1971 and is headquartered in New York, New York.
Pathfinder Cell Therapy logo

Pathfinder Cell Therapy

OTCMKTS:PFND
Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts.